These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9637197)

  • 1. Laminin-alpha2 (merosin), beta-dystroglycan, alpha-sarcoglycan (adhalin), and dystrophin expression in congenital muscular dystrophies: an immunohistochemical study.
    ter Laak HJ; Leyten QH; Gabreëls FJ; Kuppen H; Renier WO; Sengers RC
    Clin Neurol Neurosurg; 1998 Mar; 100(1):5-10. PubMed ID: 9637197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of dystrophin, the sarcoglycans, and laminin alpha2 in the muscular dystrophies.
    Jones KJ; Kim SS; North KN
    J Med Genet; 1998 May; 35(5):379-86. PubMed ID: 9610800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential expression of genes involved in muscular dystrophies during human development.
    Durand M; Suel L; Barbet JP; Beckmann JS; Fougerousse F
    Morphologie; 2002 Jun; 86(273):9-12. PubMed ID: 12224393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dystrophin-glycoproteins associated in congenital muscular dystrophy: immunohistochemical analysis of 59 Brazilian cases.
    Ferreira LG; Marie SK; Liu EC; Resende MB; Carvalho MS; Scaff M; Reed UC
    Arq Neuropsiquiatr; 2005 Sep; 63(3B):791-800. PubMed ID: 16258658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural localization of adhalin, alpha-dystroglycan and merosin in normal and dystrophic muscle.
    Cullen MJ; Walsh J; Roberds SL; Campbell KP
    Neuropathol Appl Neurobiol; 1996 Feb; 22(1):30-7. PubMed ID: 8866780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle.
    Cohn RD; Mayer U; Saher G; Herrmann R; van der Flier A; Sonnenberg A; Sorokin L; Voit T
    J Neurol Sci; 1999 Mar; 163(2):140-52. PubMed ID: 10371075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of syntrophin, dystroglycan, and merosin in a female infant with a congenital muscular dystrophy phenotype lacking cysteine-rich and C-terminal domains of dystrophin.
    Tachi N; Ohya K; Chiba S; Matsuo M; Patria SY; Matsumura K
    Neurology; 1997 Aug; 49(2):579-83. PubMed ID: 9270600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.
    Brockington M; Blake DJ; Prandini P; Brown SC; Torelli S; Benson MA; Ponting CP; Estournet B; Romero NB; Mercuri E; Voit T; Sewry CA; Guicheney P; Muntoni F
    Am J Hum Genet; 2001 Dec; 69(6):1198-209. PubMed ID: 11592034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal lamina abnormality in the skeletal muscle of Walker-Warburg syndrome.
    Vajsar J; Ackerley C; Chitayat D; Becker LE
    Pediatr Neurol; 2000 Feb; 22(2):139-43. PubMed ID: 10738921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of laminin beta 2 chain expression in congenital muscular dystrophy.
    Cohn RD; Herrmann R; Wewer UM; Voit T
    Neuromuscul Disord; 1997 Sep; 7(6-7):373-8. PubMed ID: 9327401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preserved merosin M-chain (or laminin-alpha 2) expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital muscular dystrophy.
    Voit T; Sewry CA; Meyer K; Hermann R; Straub V; Muntoni F; Kahn T; Unsöld R; Helliwell TR; Appleton R
    Neuropediatrics; 1995 Jun; 26(3):148-55. PubMed ID: 7477753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profound skeletal muscle depletion of alpha-dystroglycan in Walker-Warburg syndrome.
    Jiménez-Mallebrera C; Torelli S; Brown SC; Feng L; Brockington M; Sewry CA; Beltrán-Valero De Bernabé D; Muntoni F
    Eur J Paediatr Neurol; 2003; 7(3):129-37. PubMed ID: 12788039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy.
    Vachon PH; Xu H; Liu L; Loechel F; Hayashi Y; Arahata K; Reed JC; Wewer UM; Engvall E
    J Clin Invest; 1997 Oct; 100(7):1870-81. PubMed ID: 9312189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistochemical studies of a variant of congenital muscular dystrophy].
    Yoshioka M; Sugie K; Nishino I; Toda T
    No To Hattatsu; 2004 Jan; 36(1):55-9. PubMed ID: 14737865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electron microscopic examination of basal lamina in Fukuyama congenital muscular dystrophy.
    Ishii H; Hayashi YK; Nonaka I; Arahata K
    Neuromuscul Disord; 1997 May; 7(3):191-7. PubMed ID: 9185184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunofluorescence study of a muscle biopsy from a 1-year-old patient with Walker-Warburg syndrome.
    Villanova M; Sabatelli P; He Y; Malandrini A; Petrini S; Maraldi NM; Merlini L
    Acta Neuropathol; 1998 Dec; 96(6):651-4. PubMed ID: 9845296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of laminin subunits in congenital muscular dystrophy.
    Sewry CA; Philpot J; Mahony D; Wilson LA; Muntoni F; Dubowitz V
    Neuromuscul Disord; 1995 Jul; 5(4):307-16. PubMed ID: 7580244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminin beta 2 chain and adhalin deficiency in the skeletal muscle of Walker-Warburg syndrome (cerebro-ocular dysplasia-muscular dystrophy).
    Wewer UM; Durkin ME; Zhang X; Laursen H; Nielsen NH; Towfighi J; Engvall E; Albrechtsen R
    Neurology; 1995 Nov; 45(11):2099-101. PubMed ID: 7501167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confocal analysis of the dystrophin protein complex in muscular dystrophy.
    Draviam R; Billington L; Senchak A; Hoffman EP; Watkins SC
    Muscle Nerve; 2001 Feb; 24(2):262-72. PubMed ID: 11180210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of dystrophin, alpha-sarcoglycan, and beta-dystroglycan during skeletal muscle regeneration: immunohistochemical and western blot studies.
    Hoshino S; Ohkoshi N; Ishii A; Shoji S
    Acta Histochem; 2002; 104(2):139-47. PubMed ID: 12086334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.